NCT02741596: A reported trial by Shire
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02741596 |
|---|---|
| Title | HELP Study ExtensionTM: An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of DX-2930 for Prevention Against Acute Attacks of Hereditary Angioedema (HAE) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | May 26, 2016 |
| Completion date | Oct. 31, 2019 |
| Required reporting date | Oct. 30, 2020, midnight |
| Actual reporting date | April 28, 2020 |
| Date last checked at ClinicalTrials.gov | June 19, 2026 |
| Days late | None |